About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6641 record(s)
Req # A-2020-000582
Adverse Drug Reaction (ADR). Report number: E2B_03121361.Organization: Health Canada
March 2021
Req # A-2020-000592
Adverse Drug Reaction (ADR) for Botulinum toxin type A. Report number: E2B_03136030.Organization: Health Canada
March 2021
Req # A-2020-000593
Adverse Drug Reaction (ADR) for botulinum toxin. Report number: E2B_02925013.Organization: Health Canada
March 2021
Req # A-2020-000645
Adverse Reaction Reports (AERs). Report numbers: E2B_01554509, E2B_02541883, E2B_02456944, E2B_02693881, E2B_02797230 E2B_03154000, E2B_03157812, E2B_02968298, E2B_02568754.Organization: Health Canada
March 2021
Req # A-2020-000676
Adverse Reaction Reports (AERs). Report numbers: E2B_02847499, E2B_03166944, E2B_02888368, E2B_02940849, E2B_02957403, 000422255, E2B_03077510.Organization: Health Canada
March 2021
Req # A-2020-000717
Adverse Reaction Reports (AERs) for C1 Esterase Inhibitor. Report numbers: E2B_03054617, E2B_03152224. (AERs) for CUVITRU. Report numbers: 000911226, 000912204, 000912208. (AERs) for GAMMAGARD LIQUID. Report numbers: 000735871, 000736255,…Organization: Health Canada
March 2021
Req # A-2020-000803
Adverse Reaction Reports (AERs). Report numbers: E2B_03076723, 000912767, E2B_03006384, E2B_03206616, E2B_02720850, E2B_03224385.Organization: Health Canada
March 2021
Req # A-2020-000811
Adverse Reaction Reports (AERs). Report numbers: 000914955, 000914937, 000916806, 000917031, E2B_03199850, E2B_03226310, E2B_03253116.Organization: Health Canada
March 2021
Req # A-2020-000854
Adverse Reaction Reports (AERs). Report numbers: E2B_03186049, E2B_03186050, E2B_03192501, E2B_03193214.Organization: Health Canada
March 2021
Req # A-2020-000858
Adverse Reaction Reports (AERs). Report numbers: E2B_03146211, E2B_02894191, E2B_02196126, 000712016, E2B_01728270, E2B_02224950, E2B_02299168, E2B_02553170, 000716624, 000716626.Organization: Health Canada
March 2021